Chronic fatigue syndrome: A brief review of functional disturbances and potential therapy

Journal of Sports Medicine and Physical Fitness

Volumn 45, Issue 3, 2005, Pages 381-392

  Shephard, R J ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE   (Canada)

Author keywords

Adrenal glands; Chronic disease infections; Fibromyalgia; Hypotension; Immune system; Neurohypophysis; Overtraining; Stress

Indexed keywords

ANABOLIC AGENT; ESTROGEN; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; MINERALOCORTICOID; PLACEBO;

AEROBIC CAPACITY; AFFECT; AUTONOMIC DYSFUNCTION; AVOIDANCE BEHAVIOR; CARDIOPULMONARY HEMODYNAMICS; CHRONIC FATIGUE SYNDROME; CLINICAL TRIAL; COGNITIVE THERAPY; CORTICOSTEROID THERAPY; DETERIORATION; DIAGNOSTIC APPROACH ROUTE; ENDOCRINE DISEASE; ENVIRONMENTAL FACTOR; ESTROGEN THERAPY; EXERCISE; FUNCTIONAL ASSESSMENT; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFECTION; LONG TERM CARE; MEDLINE; MENTAL FUNCTION; MOOD; MUSCLE FUNCTION; MUSCLE STRENGTH; NUTRITIONAL DEFICIENCY; NUTRITIONAL STATUS; OVEREXERTION; PATHOPHYSIOLOGY; PERSONALITY; PHYSICAL STRESS; PSYCHOTHERAPY; REVIEW; TREATMENT INDICATION; VALIDATION PROCESS;

AUTOIMMUNITY; COGNITIVE THERAPY; EXERCISE; EXERCISE THERAPY; FATIGUE SYNDROME, CHRONIC; HUMANS; NUTRITIONAL STATUS; PHYSICAL EDUCATION AND TRAINING; SPORTS; SPORTS MEDICINE;

EID: 28544435483     PISSN: 00224707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Wessely S. Chronic fatigue: symptom and syndrome. Ann Intern Med 2001;134:838-43.
2. Hardt J, Buchwald D, Wilks D, Sharpe M, Nix WA, Egle UT. Health-related quality of life in patients with chronic fatigue syndrome: an international study. J Psychosom Res 2001;51:431-4.
3. th, 2002.
4. Shephard RJ. Chronic fatigue syndrome: an update. Sports Med 2001;31:167-94.
5. Aaron LA, Buchwald D. A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med 2001;134:868-81.
6. Wilson A, Hickie I, Hadzie-Pavlovic D, Wakefield D, Parker G, Strauss SE et al. What is chronic fatigue syndrome? Heterogeneity within an international multicentre study. Austr N Z J Psychiatr 2001;35: 520-7.
7. De Becker P, McGregor N, De Meirleir K. A definition-based analysis of symptoms in a large cohort of patients with chronic fatigue syndrome. J Intern Med 2001;250:234-40.
8. Urhausen A, Kindermann W. Diagnosis of overtraining: what tools do we have? Sports Med 2002;32:95-102.
9. Vercoulen JH, Bazelmans E, Swanink CM, Fennis JF, Galama JM, Jongen PJ et al. Physical activity in chronic fatigue syndrome: assessment and its role in fatigue. J Psychiatr Res 1997;31:661-73.
10. Wagenmakers AJM. Chronic fatigue syndrome: the physiology of people on the low end of the spectrum of physical activity? Clin Sci 1999;97:611-3.
11. Sisto SA, LaManca J, Cordero DL, Bergen MT, Ellis SP, Drastal S et al. Metabolic and cardiovascular effects of a progressive exercise test in patients with chronic fatigue syndrome. Am J Med 1996;100:634-40.
12. Inbar O, Dlin R, Rotstein A, Whipp BJ. Physiological responses to incremental exercise in patients with chronic fatigue syndrome. Med Sci Sports Exerc 2001;33:1463-70.
13. Bazelmans E, Bleijenberg G, Van der Meer JWM, Folgering H. Is physical deconditioning a perpetuating factor in chronic fatigue syndrome? A controlled study on maximal exercise performance and relations with fatigue, impairment and physical activity. Psychol Med 2001;31:107-14.
14. Sargent C, Scroop GC, Nemeth PM, Burnet RB, Buckley JD. Maximal oxygen uptake and lactate metabolism are normal in chronic fatigue syndrome. Med Sci Sports Exerc 2002;34:51-6.
15. De Becker P, Campine I, De Meierleir K. Measuring physical disability in patients with chronic fatigue syndrome using exercise testing [abstract]. Chest 1999;116:335S.
16. Fulcher KY, White PD. Strength and physiological response to exercise in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatr 2000;69:302-7.
17. LaManca JJ, Peckerman A, Walker J, Kesil W, Cook S, Taylor A et al. Cardiovascular response during head-up tilt in chronic fatigue syndrome. Clin Physiol 1999;19:111-20.
18. Dworkin HJ, Lawrie C, Bohdiewicz P, Lerner AM. Abnormal left ventricular myocardial dynamics in eleven patients with chronic fatigue syndrome. Clin Nucl Med 1994;19:675-7.
19. Streeten DHP, Bell DS. Circulating blood volume in chronic fatigue syndrome. J Chron Fatigue Syndr 1998;4:3-11.
20. Paul LM, Wood L, Maclaren W. The effect of exercise on gait and balance in patients with chronic fatigue syndrome. Gait Posture 2001;14:19-27.
21. Gordon R, Michalewski HJ, Nguyen T, Gupta S, Starr A. Cortical motor potential alterations in chronic fatigue syndrome. Int J Mol Med 1999;4:493-9.
22. McCully KK, Natelson BH. Impaired oxygen delivery to muscle in chronic fatigue syndrome. Clin Sci 1999;97:611-3.
23. De Lorenzo F, Xiao H, Mukherjee M, Harcup J, Suleiman S, Kadziola Z et al. Chronic fatigue syndrome: physical and cardiovascular deconditioning. Q J Med 1998;91:475-81.
24. Brunello N, Akiskal H, Boyer P, Gessa GL, Howland RH, Langer SZ et al. Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacologic considerations, and new therapeutic vistas. J Affect Disord 1999;52:275-90.
25. Theorell T, Blomkvist V, Lindh G, Evengard B. Critical life events, infections and symptoms during the year preceding chronic fatigue syndrome (CFS): an examination of CFS patients and subjects with a nonspecific life crisis. Psychosom Med 1999;61:304-10.
26. Van Houdenhove B, Neerinckx E, Onghena P, Lysens R, Vertommen H. Premorbid "overactive" lifestyle in chronic fatigue syndrome and fibromyalgia. An etiological factor or proof of good citizenship? J Psychosom Res 2001;51:571-6.
27. Findley JC, Kerns R, Weinberg LD, Rosenberg R. Self-efficacy as a psychological moderator of chronic fatigue syndrome. J Behav Med 1998;21:351-62.
28. Michiels V, Cluydts R. Neuropsychological functioning in chronic fatigue syndrome: a review. Acta Psychiatr Scand 2001;103:84-93.
29. Davey NJ, Puri BK, Nowicky AV, Main J, Zaman R. Voluntary motor function in patients with chronic fatigue syndrome. J Psychosom Res 2001;50:17-20.
30. Dobbs BM, Dobbs AR, Kiss I. Working memory deficits associated with chronic fatigue syndrome. J Int Neuropsychol Soc 2001;7: 285-93.
31. Smith AP, Borysiewicz L, Pollock J, Thomas M, Perry K, Llewelyn M. Acute fatigue in chronic fatigue syndrome patients. Psychol Med 1999;29:283-90.
32. MacHale SM, Larie SM, Cavanagh JT, Glabus MF, Murray CL, Goodwin GM et al. Cerebral perfusion in chronic fatigue syndrome and depression. Br J Psychiatr 2000;176:550-6.
33. Blackwood SK, MacHale SM, Power MJ, Goodwin GM, Lawrie SM. Effects of exercise on cognitive and motor function in chronic fatigue syndrome and depression. J Neurol Neurosurg Psychiatr 1998;65: 541-6.
34. Sisto SA, Tapp WN, LaManca JJ, Ling W, Korn LR, Nelson AJ et al. Physical activity before and after exercise in women with chronic fatigue syndrome. Q J Med 1998;91:465-73.
35. Clapp LL, Richardson MT, Smith JF, Wang M, Clapp AJ, Pieroni RE. Acute effects of thirty minutes of light-intensity, intermittent exercise on patients with chronic fatigue syndrome. Phys Ther 1999;79:749-56.
36. Claypoole K, Mahurin R, Fischer ME, Goldberg J, Schmaling KB, Schoene RB et al. Cognitive compromise following exercise in monozygotic twins discordant for chronic fatigue syndrome: fact or artifact? Appl Neuropsychol 2001;8:31-40.
37. Mullis R, Campbell IT, Wearden AJ, Morriss RK, Pearson DJ. Prediction of peak oxygen uptake in chronic fatigue syndrome. Br J Sports Med 1999;33:352-6.
38. Soetekouw PM, Lenders JW, Bleijenberg G, Thien T, van der Meer JW. Autonomic function in patients with chronic fatigue syndrome. Clin Autonom Res 1999;9:334-40.
39. De Becker P, Dendale P, De Meirleir K, Campine I, Vandenborne K, Hagers Y. Autonomic testing in patients with chronic fatigue syndrome. Am J Med 1998;105:228-6.
40. Streeten DH, Thomas D, Bell DS. The roles of orthostatic hypotension, orthostatic tachycardia, and subnormal erythrocyte volume in the pathogenesis of chronic fatigue syndrome. Am J Med Sci 2000; 320:1-8.
41. Naschitz JE, Sabo E, Naschitz S, Shaviv N, Rosner I, Rozenbaum M et al. Hemodynamic instability in chronic fatigue syndrome: indices and diagnostic significance. Semin Arthritis Rheum 2001;31: 199-208.
42. Cohen H, Neumann L, Kotler M, Buskila D. Autonomic nervous system derangement in fibromyalgia syndrome and related disorders. Isr Med Ass J 2001;3:755-60.
43. LaManca JJP, Peckerman A, Sisto SA, DeLuca J, Cook S, Natelson BH. Cardiovascular responses of women with chronic fatigue syndrome to stressful cognitive testing before and after strenuous exercise. Psychosom Med 2001;63:756-64.
44. Streeten DH. Role of impaired lower-limb venous innervation in the pathogenesis of the chronic fatigue syndrome. Am J Med Sci 2001;321:163-7.
45. Poole J, Herrell R, Ashton S, Goldberg J, Buchwald D. Results of isoproterenol tilt table testing in monozygotic twins discordant for chronic fatigue syndrome. Arch Intern Med 2000;160:3461-8.
46. Duprez DA, De Buyzere ML, Drieghe B, Vanhaverbeke F, Taes Y, Michielsen W et al. Long- and short-term blood pressure and R-R interval variability and psychosomatic distress in chronic fatigue syndrome. Clin Sci 1999;94:57-63.
47. Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 2000;25:1-35.
48. Demitrack MA. Neuroendocrine correlates of chronic fatigue syndrome: a brief review. J Psychiatr Res 1997;31:69-82.
49. Peroutka SJ. Chronic fatigue disorders: an inappropriate response to arginine vasopressin? Med Hypotheses 1998;50:521-3.
50. Alternus M, Dale JK, Michelson D, Demitrack MA, Gold PW, Straus SE. Abnormalities in response to vasopressin infusion in chronic fatigue syndrome. Psychoneuroendocrinology 2001;26:175-88.
51. Ottenweller JE, Sisto SA, McCarty RC, Natelson BH. Hormonal responses to exercise in chronic fatigue syndrome. Neuropsychobiology 2001;43:34-41.
52. van Rensburg SJ, Potocnik FC, Kiss T, Hugo F, van Zijl P, Mansvelt E et al. Serum concentrations of some metals and steroids in patients with chronic fatigue syndrome with reference to neurological and cognitive abnormalities. Brain Res Bull 2001;55:319-25.
53. Visser J, Graffelman W, Blauw B, Haspels J, Lentjes E, deKloet ER et al. LPS-induced IL-10 production in whole blood cultures from chronic fatigue syndrome patients is increased but supersensitive to inhibition by dexamethasone. J Neuroimmunol 2001;119:343-9.
54. Friedman TC, Echeverry D. Poland R. Orthostatic hypotension and chronic fatigue syndrome. JAMA 2001;285:1441-3.
55. Cleare AJ, Miell J, Heap E, Sookdeo S, Young L, Malhi GS et al. Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. J Clin Endocrinol Metab 2001;86:3545-54.
56. Conti F, Pittoni V, Sacerdote P, Priori R, Meroni PL, Valesini G. Decreased immunoreactive beta-endorphin in mononuclear leucocytes from patients with chronic fatigue syndrome. Clin Exp Rheumatol 1998;16:729-32.
57. Werbach MR. Nutritional strategies for treating chronic fatigue syndrome. Alt Med Rev 2000;5:93-108.
58. Castell LM, Yamamoto T, Phoenix J, Newsholme EA. The role of tryptophan in fatigue in different conditions of stress. Adv Exp Med Biol 1999;467:697-704.
59. Kreider RB. Central fatigue hypothesis and overtraining. In: Kreider RB, Fry AC, O'Toole ML, editors. Overtraining in sport. Champaign, IL.: Human Kinetics; 1998.p.309-31.
60. See DM, Cimoch P, Chou S, Chang J, Tilles J. The in vitro immunomodulatory effects of glyconutrients on peripheral blood mononuclear cells of patients with chronic fatigue syndrome. Integr Physiol Behav Sci 1998;33:280-7.
61. Rohde T, MacLean DA, Pedersen BK. Effect of glutamine supplementation on changes in the immune system induced by repeated exercise. Med Sci Sports Exerc 1998;30:856-62.
62. Warren G, McKendrick M, Peet M. The role of essential fatty acids in chronic fatigue syndrome. A case-controlled study of red-cell membrane essential fatty acids (EFA) and a placebo-controlled treatment study with high doses of EFA. Acta Neurol Scand 1999;99:112-6.
63. Logan AC, Wong C. Chronic fatigue syndrome: oxidative stress and dietary modifications. Alt Med Rev 2001;6:450-9.
64. Pall ML. Common etiology of posttraumatic stress disorder, fibromyalgia, chronic fatigue syndrome and multiple chemical sensitivity via elevated nitric oxide/peroxynitrite. Med Hypothedes 2001;57:139-45.
65. Heap LC, Peters TJ, Wessely S. Vitamin B status in patients with chronic fatigue syndrome. J Roy Soc Med 1999;92:183-5.
66. Jason LA, Taylor RR, Carrico AW. A community-based study of seasonal variation in the onset of chronic fatigue syndrome and idiopathic chronic fatigue. Chronobiol Int 2001;18:315-9.
67. Zhang QW, Natelson BH, Ottenweller JE, Servatius RJ, Nelson JJ, De Luca J et al. Chronic fatigue syndrome beginning suddenly occurs seasonally over the year. Chronobiol Int 2000;17:95-9.
68. White PD, Thomas JM, Kangro HO, Bruce-Jones WD, Amess J, Crawford DH et al. Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis. Lancet 2001;358:1946-54.
69. Shephard RJ. Physical activity, training and the immune response. Carmel, IN.: Cooper Publications; 1997.
70. Hickie IB, Bansal AS, Kirk KM, Lloyd AR, Martin NG. A twin study of the etiology of prolonged fatigue and immune activation. Twin Res 2001;4:94-102.
71. Zhang Q, Zhou XD, Denny T, Ottenweller JE, Lange G, LaManca JJ et al. Changes in immune parameters seen in Gulf War veterans but not in civilians with chronic fatigue syndrome. Clin Diagn Lab Immunol 1999;6:6-13.
72. Hassan IS, Bannister BA, Akbar A, Weir W, Bofill M. A study of the immunology of the chronic fatigue syndrome: correlation of immunologic parameters to health dysfunction. Clin Immunol Immunopathol 1998;87:60-7.
73. Visser J, Blauw B, Hinloopen B, Brommer E, de Kloet ER, Kluft C et al. CD4 T lymphocytes from patients with chronic fatigue syndrome have decreased interferon-gamma production and increased sensitivity to dexamethasone. J Infect Dis 1998;177:451-4.
74. Kavelaars A, Kuis W, Knook L, Sinnema G, Heijnen CJ. Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome. J Clin Endocrinol Metab 2000;85:692-6.
75. Natelson BH, LaManca JJ, Denny TN, Vladutiu A, Oleske J, Hill N et al. Immunologic parameters in chronic fatigue syndrome, major depression, and multiple sclerosis. Am J Med 1998;105:43S-9.
76. Whiteside TL, Friberg D. Natural killer cells and natural killer cell activity in chronic fatigue syndrome. Am J Med 1998;105: 27S-34.
77. Patarca-Montero R, Antoni M, Fletcher MA, Klimas NG. Cytokine and other immunologic markers in chronic fatigue syndrome and their relation to neuropsychological factors. Appl Neuropsychol 2001;8:51-64.
78. Kerr JR, Barah F, Mattey DL, Laing I, Hopkins SJ, Hutchinson IV et al. Circulating tumour necrosis factor-alpha and interferon-gamma are detectable during acute and convalescent parvovirus B19 infection and associated with prolonged and chronic fatigue. J Gen Virol 2001;82:3011-9.
79. Prins JB, Belijenberg G, Bazelmans E, Elving LD, de Boo TM, Severens JL et al. Cognitive behavioural therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. Lancet 2001; 357:841-7.
80. Tiersky LA, DeLuca J, Hill N, Dhar SK, Johnson SK, Lange G et al. Longitudinal assessment of neuropsychological functioning, psychiatric status, functional disability and employment status in chronic fatigue syndrome. Appl Neuropsychol 2001;8:41-50.
81. Powell P, Bentall RP, Nye FJ, Edwards RHT. Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome. Br Med J 2001;322:387-90.
82. Whiting P, Bagnall AM, Sowden AJ, Cornell JE, Mulrow CD, Ramirez G. Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. JAMA 2001;286:1360-8.
83. Dendy C, Cooper M, Sharpe M. Interpretation of symptoms in chronic fatigue syndrome. Behav Res Ther 2001;39:1369-80.
84. Wessely S, Hotopf M, Sharpe M. Chronic fatigue and its syndromes. Oxford, UK.: Oxford University Press; 1998.
85. Akagi H, Klimes I, Bass C. Cognitive behavioral therapy for chronic fatigue syndrome in a general hospital-feasible and effective. Gen Hosp Psychiatr 2001;23:254-60.
86. Ridsdale L, Godfrey E, Chalder T, Seed P, King M, Wallace P et al. Chronic fatigue in general practice: is counselling as good as cognitive behaviour therapy? A UK randomized trial. Br J Gen Pract 2001;51:19-24.
87. Reid S, Chalder T, Cleare A, Hotopf M, Wessely S. Chronic fatigue syndrome. Br Med J 2000;320:292-6.
88. Jason LA, Melrose H, Lerman A, Burroughs V, Lewis K, King CP et al. Managing chronic fatigue syndrome: overview and case study. Am Assoc Occup Hlth Nurs J 1999;47:17-21.
89. Jason LA, King CP, Frankenberry EL, Jordan KM, Tryon WW, Rademaker F et al. Chronic fatigue syndrome: assessing symptoms and activity level. J Clin Psychol 1999;55:411-24.
90. Young M. How I treat return to sport after post-viral fatigue. Br J Sports Med 1999;33:173.
91. Deale A, Hussain K, Chalder T, Wessely S. Long-term outcome of cognitive behavior therapy versus relaxation therapy for chronic fatigue syndrome: a 5-year follow-up study. Am J Psychiatr 2001;158:2038-42.
92. Coutts R, Weatherby R, Davie A. The use of a symptom "self- report" inventory to evaluate the acceptability and efficacy of a walking program for patients suffering with chronic fatigue syndrome. J Psychosom Res 2001;51:425-9.
93. Wearden AJ, Morris RK, Mullis R, Strickland PL, Pearson D, Appleby L et al. Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome. Br J Psychiatr 1998;172:485-90.
94. Fulcher KY, White PD. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. Br Med J 1997; 314:1647-52.
95. Greenslade RA. Presumed infectious mononucleosis in a college basketball player. Phys Sportsmed 2000;28:79-86.
96. MacKnight JM. Infectious mononucleosis: ensuring a safe return to sport. Phys Sportsmed 2002;30:27-41.
97. Baschetti R. Orthostatic hypotension and chronic fatigue syndrome. JAMA 2001;285:1441-3.
98. Rowe PC, Calkins HD, DeBusk KN, McKenzie R, Anand R, Sharma G et al. Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. JAMA 2001;285:52-9.
99. Peterson PK, Pheley A, Schroeppel J, Schenck C, Marshall P, Kind A et al. A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome. Arch Intern Med 1998;158: 908-14.
100. Panay N, Studd JW. The psychotherapeutic effect of estrogens. Gynecol Endocrinol 1998;12:353-65.